Proactive research analyst Robin Davison tells Katie about his report compiled on MGC Pharmaceuticals.
He focuses on the results of an Australian study that aimed to combat mild Alzheimers in care home patients.
The drug was safe for all patients and all three measured scores trended in the right direction, suggesting efficacy.